Fig. 1From: BMP signaling in cancer stemness and differentiationSchematic illustration of BMP signaling pathway. Activation of this pathway occurs when BMP ligand dimers bind to two homologous type II receptors, facilitating the formation of a tetramer with the two type I receptors. The type II receptor kinase, constitutively active, phosphorylates specific serine residues in the type I receptors, leading to their activation. There are four type I BMP receptors: ALK1 (ACVRL1), ALK2 (ACVR1), ALK3 (BMPRIA), and ALK6 (BMPRIB), and three type II BMP receptors: BMP receptor type II (BMPR2), activin type II receptor A (ACVR2A), and activin type II receptor B (ACVR2B). The subsequent steps involve the activation of type I receptors, leading to the phosphorylation of receptor-regulated SMADs (R-SMADs) transcription factors, specifically SMAD1/5/8. In contrast, TGFβ signaling involves SMAD2/3. The R-SMADs form a heteromeric complex with the co-SMAD, SMAD4, and translocate into the nucleus to regulate target gene expression transcriptionally. Created with BioRender.comBack to article page